Candel Therapeutics(CADL)
$8.39-0.83 (-9.00%)
CADL
Candel Therapeutics financials statements
$8.39
At close:-0.83 (-9.00%)
Want to see CADL full AI Analyst Report?
Candel Therapeutics (CADL) Income Statement
495 Followers
Candel Therapeutics Income Statement
Last quarter (Q2 2026), Candel Therapeutics's total revenue was $0.00. In Q2, Candel Therapeutics's net income was $-38.91M. See Candel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 125.00K | $ 125.00K | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 125.00K | $ 125.00K | |
| $ 48.27M | $ 33.37M | $ 38.39M | $ 34.80M | $ 25.85M | |
| Depreciation and Amortization | $ 845.00K | $ 990.00K | $ 960.00K | $ 778.00K | $ 232.00K |
| $ -35.22M | $ -52.10M | $ -34.38M | $ -16.31M | $ -35.89M | |
| $ -48.27M | $ -33.37M | $ -38.39M | $ -34.67M | $ -25.73M | |
| $ 10.08M | $ -21.81M | $ 452.00K | $ 15.93M | $ -10.40M | |
| $ -38.18M | $ -55.18M | $ -37.94M | $ -18.79M | $ -36.12M | |
| $ -38.18M | $ -55.18M | $ -37.94M | $ -18.79M | $ -36.12M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.72 | $ -1.74 | $ -1.31 | $ -0.10 | $ -1.91 |
| Diluted EPS | $ -0.72 | $ -1.74 | $ -1.31 | $ -0.10 | $ -1.91 |
| Weighted Average Shares Outstanding | 52.96M | 31.68M | 28.94M | 28.82M | 18.87M |
| Weighted Average Shares Outstanding (Diluted) | 52.96M | 31.68M | 28.94M | 28.82M | 18.87M |
Currency in USD
